ADICET BIO INC. - COMMON STOCK

Adicet Bio Announces Positive Interim Clinical Data From First-Ever Allogeneic, Off-The-Shelf, Gamma Delta CAR T Investigational Cell Therapy

06 Dec 2021 07:00:01 By Nasdaq GlobeNewswire

Adicet Bio to Host Webcast Presentation of ADI-001 Interim Clinical Data in B Cell Non-Hodgkin’s Lymphoma

29 Nov 2021 07:00:00 By Nasdaq GlobeNewswire

Adicet Announces Appointment of Dr. Michael G. Kauffman to the Board of Directors

18 Nov 2021 07:00:01 By Nasdaq GlobeNewswire

Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting

12 Nov 2021 07:00:02 By Nasdaq GlobeNewswire

Adicet Reports Third Quarter 2021 Financial Results and Provides Business Updates

10 Nov 2021 16:01:00 By Nasdaq GlobeNewswire

Adicet Bio to Participate in Stifel 2021 Virtual Healthcare Conference

08 Nov 2021 07:00:01 By Nasdaq GlobeNewswire

Adicet Announces Trials in Progress Poster Presentation for ADI-001 at 2021 ASH Annual Meeting

04 Nov 2021 09:00:02 By Nasdaq GlobeNewswire

Adicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer

12 Oct 2021 16:10:00 By Nasdaq GlobeNewswire

Adicet to Present Preclinical Data from Allogeneic Gamma Delta T Cell Platform at SITC 36th Annual Meeting

04 Oct 2021 07:00:00 By Nasdaq GlobeNewswire

Adicet Bio Collaborates with Twist Bioscience to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics

13 Sep 2021 08:00:01 By Nasdaq GlobeNewswire

Adicet Bio to Participate in Upcoming Investor Conferences

02 Sep 2021 16:53:54 By Nasdaq GlobeNewswire

Adicet Reports Second Quarter 2021 Financial Results and Provides Business Updates

12 Aug 2021 16:01:00 By Nasdaq GlobeNewswire

Adicet Bio to Participate in Upcoming Investor Conferences

02 Aug 2021 07:00:00 By Nasdaq GlobeNewswire

Adicet Bio Announces Formation of Scientific Advisory Board

15 Jul 2021 07:00:00 By Nasdaq GlobeNewswire

Adicet Bio Added to the Russell 2000® Index

28 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

Adicet Bio to Participate in Upcoming Investor Conferences

18 May 2021 16:10:00 By Nasdaq GlobeNewswire

Adicet Reports First Quarter 2021 Financial Results and Provides Business Updates

17 May 2021 07:01:00 By Nasdaq GlobeNewswire

Adicet Bio to Participate in Fireside Chat at the 7th Annual Truist Securities Life Sciences Summit

29 Apr 2021 07:00:03 By Nasdaq GlobeNewswire

Adicet Bio to Participate in the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference

15 Apr 2021 07:00:02 By Nasdaq GlobeNewswire

Adicet Bio Appoints Dr. Blake Aftab as Vice President of Research

13 Apr 2021 07:00:00 By Nasdaq GlobeNewswire